Outcome of Triple Negative Breast Cancer in Patients with or without Deleterious BRCA Mutations

被引：0
|
作者：
Arun, B. K. [1 ]
Gutierrez-Barrera, A. M. [1 ]
Akar, U. [1 ]
Litton, J. K. [1 ]
Albarracin, C. [1 ]
Gonzalez-Angulo, A. M. [1 ]
Hortobagyi, G. N. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P6-10-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-10-04
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Wong-Brown, Michelle W.
    Meldrum, Cliff J.
    Carpenter, Jane E.
    Clarke, Christine L.
    Narod, Steven A.
    Jakubowska, Anna
    Rudnicka, Helena
    Lubinski, Jan
    Scott, Rodney J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 71 - 80
  • [22] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Michelle W. Wong-Brown
    Cliff J. Meldrum
    Jane E. Carpenter
    Christine L. Clarke
    Steven A. Narod
    Anna Jakubowska
    Helena Rudnicka
    Jan Lubinski
    Rodney J. Scott
    [J]. Breast Cancer Research and Treatment, 2015, 150 : 71 - 80
  • [23] Prevalence of BRCA1 mutations in triple negative breast cancer (BC).
    Kandel, M. J.
    Stadler, Z.
    Masciari, S.
    Collins, L.
    Schnitt, S.
    Harris, L.
    Miron, A.
    Richardson, A.
    Garber, J. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 5S - 5S
  • [24] Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
    Pogoda, Katarzyna
    Niwinska, Anna
    Sarnowska, Elzbieta
    Nowakowska, Dorota
    Jagiello-Gruszfeld, Agnieszka
    Siedlecki, Janusz
    Nowecki, Zbigniew
    [J]. JOURNAL OF ONCOLOGY, 2020, 2020
  • [25] Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer
    Hartman, Anne-Renee
    Kaldate, Rajesh R.
    Sailer, Lisa M.
    Painter, Lisa
    Grier, Charles E.
    Endsley, Robbin R.
    Griffin, Marlena
    Hamilton, Stephanie A.
    Frye, Cynthia A.
    Silberman, Mark A.
    Wenstrup, Richard J.
    Sandbach, John F.
    [J]. CANCER, 2012, 118 (11) : 2787 - 2795
  • [26] BRCA mutations among triple negative breast cancer without family history of breast and ovarian cancer: The Modena family cancer clinic experience
    Molinaro, E.
    Venturelli, M.
    Toss, A.
    Piombino, C.
    Barbieri, E.
    Marcheselli, L.
    Marchi, I.
    Tagliafico, E.
    Cascinu, S.
    Cortesi, L.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [27] Triple-negative breast cancer with or without BRCA mutation: looking at the future
    Ballatore, Z.
    Bracci, R.
    Bianchi, F.
    Pistelli, M.
    Maccaroni, E.
    Belvederesi, L.
    Brugiati, C.
    Pagliaretta, S.
    Pagliacci, A.
    Battelli, N.
    Berardi, R.
    [J]. BREAST, 2016, 29 : S21 - S21
  • [28] Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations
    Lee, JS
    John, EM
    McGuire, V
    Felberg, A
    Ostrow, KL
    DiCioccio, RA
    Li, FP
    Miron, A
    West, DW
    Whittemore, AS
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (02) : 359 - 363
  • [29] Prevalence of BRCA1 and BRCA2 Germline Mutations Among Pakistani Patients With Triple Negative Breast Cancer
    Rashid, M.
    Bajwa, S.
    Muhammad, N.
    Gull, S.
    Faisal, S.
    Amin, A.
    Loya, A.
    Hamann, U.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S254 - S255
  • [30] PARP Inhibitors in Triple-Negative Breast Cancer Including Those With BRCA Mutations
    Layman, Rachel M.
    Arun, Banu
    [J]. CANCER JOURNAL, 2021, 27 (01): : 67 - 75
12345